Food and Drug Administration

Cardiovascular and Renal Drugs Advisory Committee

April 12, 2002

NDA 20-386/S-028, COZAAR™ Tablets (Losartan Potassium), For the treatment of type 2 diabetic patients with nephropathy

Briefing Information

Sponsor - Merck Research Laboratories   pdf

Food and Drug Administration

Summary of Trials   pdf   htm   doc

Medical Review   pdf   htm   doc

Medical Review Addendum   pdf   htm   doc

Statistical Review   pdf   htm   doc

Statistical Review Addendum   pdf   htm   doc

Bibliography  pdf   htm  doc